Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience

Abstract Background This study was designed to investigate clinical efficiency and application indications of hepatic lobe hyperplasia techniques for advanced hepatic alveolar echinococcosis (AE) patients. Methods A retrospective case series covering 19 advanced hepatic AE patients admitted to the F...

Full description

Bibliographic Details
Main Authors: Qiang Guo, Maolin Wang, Kai Zhong, Jialong Li, Tiemin Jiang, Bo Ran, Paizula Shalayiadang, Ruiqing Zhang, Talaiti Tuergan, Tuerganaili Aji, Yingmei Shao
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Surgery
Subjects:
Online Access:https://doi.org/10.1186/s12893-022-01864-w
_version_ 1811177851717681152
author Qiang Guo
Maolin Wang
Kai Zhong
Jialong Li
Tiemin Jiang
Bo Ran
Paizula Shalayiadang
Ruiqing Zhang
Talaiti Tuergan
Tuerganaili Aji
Yingmei Shao
author_facet Qiang Guo
Maolin Wang
Kai Zhong
Jialong Li
Tiemin Jiang
Bo Ran
Paizula Shalayiadang
Ruiqing Zhang
Talaiti Tuergan
Tuerganaili Aji
Yingmei Shao
author_sort Qiang Guo
collection DOAJ
description Abstract Background This study was designed to investigate clinical efficiency and application indications of hepatic lobe hyperplasia techniques for advanced hepatic alveolar echinococcosis (AE) patients. Methods A retrospective case series covering 19 advanced hepatic AE patients admitted to the First Affiliated Hospital of Xinjiang Medical University from September 2014 to December 2021 and undergoing hepatic lobe hyperplasia techniques due to insufficient remnant liver volume were analyzed. Changes of liver function, lesions volume, remnant liver volume, total liver volume before and after operation have been observed. Results Among the patients, 15 underwent portal vein embolization (PVE). There was no statistical difference in total liver volume and lesions volume before and after PVE (P > 0.05). However, the remnant liver volume was significantly increased after PVE (P < 0.05). The median monthly increase rate in future liver remnant volume (FLRV) after PVE stood at 4.49% (IQR 3.55–7.06). Among the four patients undergoing two-stage hepatectomy (TSH), FLRV was larger than that before the first stage surgery, and the median monthly increase rate in FLRV after it stood at 3.34% (IQR 2.17–4.61). Despite no statistical difference in total bilirubin (TBil), albumin (Alb), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma-glutamyl transpeptidase (GGT) in all patients with PVE, four patients who underwent TSH showed a decrease in ALT, AST and GGT. During the waiting process before the second stage operation, no serious complications occurred in all patients. Conclusions For patients suffering from advanced hepatic AE with insufficient FLRV, PVE and TSH are safe and feasible in promoting hepatic lobe hyperplasia.
first_indexed 2024-04-11T06:09:20Z
format Article
id doaj.art-139464317cd143a7a33223c4ec9ace77
institution Directory Open Access Journal
issn 1471-2482
language English
last_indexed 2024-04-11T06:09:20Z
publishDate 2022-12-01
publisher BMC
record_format Article
series BMC Surgery
spelling doaj.art-139464317cd143a7a33223c4ec9ace772022-12-22T04:41:22ZengBMCBMC Surgery1471-24822022-12-0122111010.1186/s12893-022-01864-wApplication of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experienceQiang Guo0Maolin Wang1Kai Zhong2Jialong Li3Tiemin Jiang4Bo Ran5Paizula Shalayiadang6Ruiqing Zhang7Talaiti Tuergan8Tuerganaili Aji9Yingmei Shao10Department of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityDepartment of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical UniversityAbstract Background This study was designed to investigate clinical efficiency and application indications of hepatic lobe hyperplasia techniques for advanced hepatic alveolar echinococcosis (AE) patients. Methods A retrospective case series covering 19 advanced hepatic AE patients admitted to the First Affiliated Hospital of Xinjiang Medical University from September 2014 to December 2021 and undergoing hepatic lobe hyperplasia techniques due to insufficient remnant liver volume were analyzed. Changes of liver function, lesions volume, remnant liver volume, total liver volume before and after operation have been observed. Results Among the patients, 15 underwent portal vein embolization (PVE). There was no statistical difference in total liver volume and lesions volume before and after PVE (P > 0.05). However, the remnant liver volume was significantly increased after PVE (P < 0.05). The median monthly increase rate in future liver remnant volume (FLRV) after PVE stood at 4.49% (IQR 3.55–7.06). Among the four patients undergoing two-stage hepatectomy (TSH), FLRV was larger than that before the first stage surgery, and the median monthly increase rate in FLRV after it stood at 3.34% (IQR 2.17–4.61). Despite no statistical difference in total bilirubin (TBil), albumin (Alb), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma-glutamyl transpeptidase (GGT) in all patients with PVE, four patients who underwent TSH showed a decrease in ALT, AST and GGT. During the waiting process before the second stage operation, no serious complications occurred in all patients. Conclusions For patients suffering from advanced hepatic AE with insufficient FLRV, PVE and TSH are safe and feasible in promoting hepatic lobe hyperplasia.https://doi.org/10.1186/s12893-022-01864-wHepatic alveolar echinococcosisSelective portal vein embolizationTwo-stage hepatectomyFuture liver remnant volume
spellingShingle Qiang Guo
Maolin Wang
Kai Zhong
Jialong Li
Tiemin Jiang
Bo Ran
Paizula Shalayiadang
Ruiqing Zhang
Talaiti Tuergan
Tuerganaili Aji
Yingmei Shao
Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience
BMC Surgery
Hepatic alveolar echinococcosis
Selective portal vein embolization
Two-stage hepatectomy
Future liver remnant volume
title Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience
title_full Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience
title_fullStr Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience
title_full_unstemmed Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience
title_short Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience
title_sort application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis a single centre experience
topic Hepatic alveolar echinococcosis
Selective portal vein embolization
Two-stage hepatectomy
Future liver remnant volume
url https://doi.org/10.1186/s12893-022-01864-w
work_keys_str_mv AT qiangguo applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT maolinwang applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT kaizhong applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT jialongli applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT tieminjiang applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT boran applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT paizulashalayiadang applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT ruiqingzhang applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT talaitituergan applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT tuerganailiaji applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience
AT yingmeishao applicationofhepaticlobehyperplasiatechniquesinthetreatmentofadvancedhepaticalveolarechinococcosisasinglecentreexperience